课题基金 / 基金详情

Integration of physiological tissue models and machine learning to understand genomic instability from oncogene activation to cancer initiation

Integration of physiological tissue models and machine learning to understand genomic instability from oncogene activation to cancer initiation
整合生理组织模型和机器学习,以了解从癌基因激活到癌症发生的基因组不稳定性
批准号:
MR/W031442/1
负责人:
Eva Petermann
金额:
$122.62万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2022
资助国家:
英国
项目状态:
未结题
起止时间:
2022 至 --

项目摘要

项目成果

Eva Petermann的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Genes that cause abnormal growth of cells and development of cancer are called oncogenes. While oncogenes often arise from mutation of cellular genes, several types of viruses that can cause cancer, such as human papillomavirus (HPV), bring viral oncogenes into the cells they infect. Oncogenes can induce 'replication stress' (called oncogene-induced replication stress or Oi-RS), which is characterised by the frequent stalling or slowing of DNA replication when chromosomes are copied. This causes more mutations in the chromosomes, which is called genomic instability. While replication stress is common in established cancers, it has been discovered that it might also occur in pre-cancerous and early cancer tissues, leading to the hypothesis that Oi-RS is an initial driver of cancer but there is currently no direct evidence for this from existing experimental models of cancer development. Moreover, it is not known how early replication stress causes a healthy cell to become cancerous. Discovery of the initiating mechanisms leading to genomic instability and cancer would provide a vital step forward in understanding what causes cells to become cancerous and will be instrumental in improving early detection and treatment of cancer. We propose to use oncogenic HPV infection of human skin cells, the natural target cell of HPV, as a human tissue model system to analyse the precise steps from Oi-RS and genomic instability to cancer initiation. HPV causes >600,000 cancers per year worldwide that are characterised by high levels of genomic instability. Infection with high-risk types of HPV is a very useful model for Oi-RS and genomic instability during early cancer development, because viral oncogenes rapidly cause replication stress and genomic instability. To date however, no team has yet combined expertise to establish the precise pathways from HPV infection, replication stress and genomic instability, through to cancer formation in relevant human skin models. Our team comprises a tumour virologist, two cell biologists and a computational scientist. Together, we cross multiple biology disciplines from molecules to human tissue models and will bring diverse methods and technologies to investigate Oi-RS in a model of HPV infection. Our expertise ranges from molecular biochemistry and cell biology to computational biology and the application of artificial intelligence. Importantly, the individual partners all have a fundamental interest in how replication stress and genome instability contribute to cancer development. This project will for the first time bring together distinct backgrounds and disciplines to unravel the molecular events between Oi-RS, genomic instability, and cancer development. We will integrate single cell- and single molecule sequencing technology and machine learning-based detection of replication stress to interrogate the steps from early establishment of HPV in skin cells to the development of invasive cancer cells.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1001/jamaoto.2023.1730
发表时间: 2023-07-27
期刊: JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY
影响因子: 7.8
作者: [Califano,Joseph, Yousef,Andrew, Mehanna,Hisham]
通讯作者: Mehanna,Hisham
DOI: 10.1016/j.molcel.2022.08.026
发表时间: 2022-09
期刊: Molecular cell
影响因子: 16
作者: [E. Petermann]
通讯作者: E. Petermann
DOI: 10.1016/j.coviro.2022.101257
发表时间: 2022-08
期刊: Current opinion in virology
影响因子: 5.9
作者: [C. S. Varghese;Joanna L. Parish;J. Ferguson]
通讯作者: C. S. Varghese;Joanna L. Parish;J. Ferguson
Characterising novel recombination pathways at DNA adducts of the environmental mutagen BPDE
  • 批准号:
    MR/S021310/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $46.49万
  • 财政年份:
    2019
  • 负责人:
    Eva Petermann
  • 依托单位:
Role of BRCA2 in the response to replication inhibitors
  • 批准号:
    MR/J007595/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $44.56万
  • 财政年份:
    2012
  • 负责人:
    Eva Petermann
  • 依托单位:
国内基金
海外基金
生理/病理应激差异化调控肝再生的“蓝斑—中缝”神经环路机制
  • 批准号:
    82371517
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    杨立群
  • 依托单位:
羊草子株出生、发育及成穗的生理与分子机制
  • 批准号:
    31172259
  • 项目类别:
    面上项目
  • 资助金额:
    56.0万元
  • 批准年份:
    2011
  • 负责人:
    穆春生
  • 依托单位: